1. Home
  2. VMI vs CORT Comparison

VMI vs CORT Comparison

Compare VMI & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VMI
  • CORT
  • Stock Information
  • Founded
  • VMI 1946
  • CORT 1998
  • Country
  • VMI United States
  • CORT United States
  • Employees
  • VMI N/A
  • CORT N/A
  • Industry
  • VMI Metal Fabrications
  • CORT Biotechnology: Pharmaceutical Preparations
  • Sector
  • VMI Industrials
  • CORT Health Care
  • Exchange
  • VMI Nasdaq
  • CORT Nasdaq
  • Market Cap
  • VMI 7.2B
  • CORT 7.6B
  • IPO Year
  • VMI N/A
  • CORT N/A
  • Fundamental
  • Price
  • VMI $419.23
  • CORT $72.05
  • Analyst Decision
  • VMI Buy
  • CORT Strong Buy
  • Analyst Count
  • VMI 4
  • CORT 4
  • Target Price
  • VMI $456.67
  • CORT $139.00
  • AVG Volume (30 Days)
  • VMI 146.4K
  • CORT 949.8K
  • Earning Date
  • VMI 10-21-2025
  • CORT 11-04-2025
  • Dividend Yield
  • VMI 0.65%
  • CORT N/A
  • EPS Growth
  • VMI N/A
  • CORT N/A
  • EPS
  • VMI 11.66
  • CORT 1.11
  • Revenue
  • VMI $4,103,136,000.00
  • CORT $716,080,000.00
  • Revenue This Year
  • VMI $1.77
  • CORT $28.85
  • Revenue Next Year
  • VMI $5.21
  • CORT $34.98
  • P/E Ratio
  • VMI $35.96
  • CORT $64.65
  • Revenue Growth
  • VMI 1.23
  • CORT 25.71
  • 52 Week Low
  • VMI $250.07
  • CORT $42.01
  • 52 Week High
  • VMI $427.81
  • CORT $117.33
  • Technical
  • Relative Strength Index (RSI)
  • VMI 63.04
  • CORT 38.65
  • Support Level
  • VMI $411.00
  • CORT $70.89
  • Resistance Level
  • VMI $422.83
  • CORT $74.77
  • Average True Range (ATR)
  • VMI 12.62
  • CORT 4.20
  • MACD
  • VMI 0.54
  • CORT -1.06
  • Stochastic Oscillator
  • VMI 78.98
  • CORT 14.47

About VMI Valmont Industries Inc.

Valmont Industries Inc, along with its subsidiaries, operates as a manufacturer of products and services for infrastructure and agriculture markets. Its reportable segments are Infrastructure and Agriculture. The company generates maximum revenue from the Infrastructure segment, which includes the manufacturing and distribution of products and solutions to serve the infrastructure markets of utility, solar, lighting and transportation, and telecommunications, along with coatings services to protect metal products. The Agriculture segment provides irrigation equipment components, including aftermarket parts and tubular products, and technology solutions for precision agriculture. Geographically, it derives key revenue from the United States, followed by Australia, Brazil, and other regions.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Share on Social Networks: